Active ingredientRucaparibCat. No. P-R095-001CAS 283173-50-2Family · Pharmaceutical analytical standards
Rucaparib
An inhibitor of the PARP enzyme, which cells use to repair DNA, approved in the United States in 2016 for previously treated advanced ovarian cancer and later also for certain BRCA-mutated prostate cancers. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It grew out of a collaboration between researchers at Newcastle University, in England, and a team of chemists in San Diego, California.
Go to the active ingredient →Active ingredientRucaparibCat. No. P-R095-001CAS 283173-50-2
Active ingredientRucaparib PhosphateCat. No. P-R095-002CAS 459868-92-9
Isotopically labelledRucaparib-d3Cat. No. P-R095-003CAS 2271225-13-7
NitrosamineN1-Nitroso RucaparibCat. No. P-R095-004
Active ingredientRucaparib CamsylateCat. No. P-R095-005CAS 1859053-21-6
ImpurityRucaparib Carboxylic AcidCat. No. P-R095-006CAS 1577998-89-0
ImpurityRucaparib Impurity 1Cat. No. P-R095-007CAS 2306161-16-8
ImpurityRucaparib Impurity 2Cat. No. P-R095-008CAS 2306160-67-6
ImpurityRucaparib Impurity 3Cat. No. P-R095-009CAS 2331277-14-4
ImpurityRucaparib Impurity 4Cat. No. P-R095-010CAS 283173-84-2
ImpurityRucaparib Impurity 5Cat. No. P-R095-011CAS 1577983-73-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.